The Anti-Nucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection for Hemodialysis Patients

The Anti-Nucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection for Hemodialysis Patients

<i><b>Background:</b></i> Hemodialysis patients, due to impaired kidney function and compromised immune responses, face increased risks from SARS-CoV-2. Anti-nucleocapsid IgG (anti-IgG N) antibodies are a commonly used marker to assess prior infection in the general populatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Akemi Hara, Shun Watanabe, Toyoaki Sawano, Yuki Sonoda, Hiroaki Saito, Akihiko Ozaki, Masatoshi Wakui, Tianchen Zhao, Chika Yamamoto, Yurie Kobashi, Toshiki Abe, Takeshi Kawamura, Akira Sugiyama, Aya Nakayama, Yudai Kaneko, Hiroaki Shimmura, Masaharu Tsubokura
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Vaccines
Subjects:
COVID-19
renal dialysis
immunoglobulin G
nucleocapsid proteins
serologic tests
Online Access:https://www.mdpi.com/2076-393X/13/7/750
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items